{
"id":"mk19_a_nr_s6",
"subspecialtyId":"nr",
"title":"Movement Disorders",
"jsonContent":{
"type":"section",
"id":"mk19_a_nr_s6",
"title":{
"__html":"Movement Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"2f49ee",
"children":[
"Movement Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s6_1",
"title":{
"__html":"Overview of Movement Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"9f3eed",
"children":[
"Overview of Movement Disorders"
]
},
"children":[
{
"type":"p",
"hlId":"53fc10",
"children":[
"Movement disorders are characterized by hypokinetic and hyperkinetic patterns of motor output. The most typical hypokinetic pattern, parkinsonism, is characterized by paucity and slowness of movements. Hyperkinetic disorders are categorized on the basis of the type of involuntary excessive movements displayed ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t31",
"wrapId":"1",
"children":[
"Table 31"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_nr_t31"
]
},
{
"type":"p",
"hlId":"864c54",
"children":[
"Neurologic examination of movement disorders should include detailed assessment of motor function and gait. The key features in the classification of movement disorders are the speed, amplitude, and fatigability of voluntary movements and the rhythmicity, suppressibility, randomness, and directionality of hyperkinetic movements. Muscle tone should be assessed for rigidity, which is an increase in resistance to passive movements that is independent of the velocity and direction of those movements. Gait examination should consider the base of standing, pace of ambulation, stride length, foot clearance off the ground, postural stability, and arm swing."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"6c2491",
"children":[
"The key features in the classification of movement disorders are the speed, amplitude, and fatigability of voluntary movements and the rhythmicity, suppressibility, randomness, and directionality of hyperkinetic movements."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2",
"title":{
"__html":"Hypokinetic Movement Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"7e22aa",
"children":[
"Hypokinetic Movement Disorders"
]
},
"children":[
{
"type":"p",
"hlId":"f58ef8",
"children":[
"The most common type of hypokinetic movement disorder is parkinsonism. Parkinson disease is the most common form of parkinsonism; Parkinson-plus syndromes combine features of parkinsonism with other features found in the patient's history or physical examination. Vascular parkinsonism results from microvascular disease or large strokes and is characterized by predominant gait impairment with relative sparing of upper extremities. Parkinsonism also may arise as an adverse effect of medication. Some patients with normal pressure hydrocephalus exhibit parkinsonism with gait instability, dementia, and urinary incontinence (see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s5_5_2_2",
"children":[
"Cognitive Impairment"
]
},
")."
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_1",
"title":{
"__html":"Parkinson Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"729d4c",
"children":[
"Parkinson Disease"
]
},
"children":[
{
"type":"p",
"hlId":"2d439a",
"children":[
"Parkinson disease is a slowly progressive neurodegenerative disorder involving the gradual loss of dopamine-producing neurons in the substantia nigra. Pathologic findings include Lewy bodies, which are intracytoplasmic eosinophilic inclusions composed of α-synuclein and ubiquitin. Both genetic influences and exposure to certain environmental factors, including pesticides, can increase the risk for Parkinson disease. Aging is a major risk factor, and a sharp rise in global incidence is expected over the next 20 years. Patients with the onset of movement disorders before age 40 years should be screened for Wilson disease."
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_1_1",
"title":{
"__html":"Clinical Features of Parkinson Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"1e4211",
"children":[
"Clinical Features of Parkinson Disease"
]
},
"children":[
{
"type":"p",
"hlId":"5f83c3",
"children":[
"Parkinson disease has four cardinal signs: tremor at rest, bradykinesia, rigidity, and gait/balance impairment. Resting tremor is characteristically unilateral at onset and remains asymmetric; it most commonly is noticed in the upper extremities and jaw (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v09",
"wrapId":"2",
"children":[
"Video 9"
]
}
]
},
"). If a resting tremor is absent, a tremor typically emerges after few seconds of outstretched posturing of the arms and during ambulation. Bradykinesia is characterized by progressive decrements in speed and amplitude of repetitive movements. This feature often is associated with reductions in facial expression and arm swing. Small handwriting (micrographia) is common, and patients may report difficulty with both fine and gross movements. Speech becomes slower with a low-volume voice. Rigidity, manifesting as increased resistance to movement, is often asymmetric, may occur on the same side as tremor, and may be “cogwheel” with intermittent release of the rigidity with passive movement, which results in a jerking or ratcheting quality of movement. As many as 30% of patients with Parkinson disease have a tremor-free akinetic rigid syndrome at presentation. Gait disturbance manifests as a slow, narrow-based, and shuffling gait with associated reduced arm swings, stooped posture, and imbalance when turning (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v10",
"wrapId":"2",
"children":[
"Video 10"
]
}
]
},
"). As the disease progresses, severe freezing of gait and postural instability are noted. In contrast, cerebellar ataxic gait is characterized by a wide base, frequent truncal swaying and veering, and impaired tandem walking in a straight line (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v11",
"wrapId":"2",
"children":[
"Video 11"
]
}
]
},
"). Early prominent postural instability with frequent falls is not typical in Parkinson disease and suggests a Parkinson-plus condition."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_nr_v09",
"mk19_a_nr_v10",
"mk19_a_nr_v11"
]
},
{
"type":"p",
"hlId":"5c9ccc",
"children":[
"Parkinson disease also is associated with various nonmotor symptoms, ranging from autonomic dysfunction to problems with sleep, mood, and cognition ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t32",
"wrapId":"3",
"children":[
"Table 32"
]
}
]
},
")"
]
},
". Premotor symptoms, including hyposmia (diminished sense of smell), constipation, and rapid eye movement (REM) sleep behavior disorder (RBD) (see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s6_3_6",
"children":[
"Restless Legs Syndrome and Sleep-Related Movement Disorders"
]
},
"), may precede onset of motor symptoms by years."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_nr_t32"
]
},
{
"type":"p",
"hlId":"aa9198",
"children":[
"Cognitive impairment in Parkinson disease is not uncommon and initially involves mild subcortical deficits, especially in processing speed, short-term memory, and attention domains. Cortical functions, such as language and declarative memory (memory of facts and events), are relatively spared. As many as a third of patients may develop dementia in the later stages of Parkinson disease, but early cognitive impairment is a red flag pointing to other diagnoses, such as dementia with Lewy bodies (see ",
{
"type":"cross-reference",
"target":"mk19_a_nr_s5_5_2_1",
"children":[
"Cognitive Impairment"
]
},
")."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_1_2",
"title":{
"__html":"Diagnosis of Parkinson Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"abe03f",
"children":[
"Diagnosis of Parkinson Disease"
]
},
"children":[
{
"type":"p",
"hlId":"588e7d",
"children":[
"The diagnosis of Parkinson disease requires the presence of bradykinesia and at least one other cardinal feature and the absence of red flags for atypical forms of parkinsonism ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t33",
"wrapId":"4",
"children":[
"Table 33"
]
}
]
},
")"
]
},
". A therapeutic trial of levodopa also can help when the diagnosis is in question; patients with Parkinson disease usually respond well, but other disorders rarely improve with levodopa. Brain imaging is recommended to rule out vascular disease and hydrocephalus. A dopamine transporter scan, such as a single-photon emission CT scan of the brain using ioflupane-123 ligand, can be used as a confirmatory test. Its use, however, should be limited to select patients in whom the differentiation between Parkinson disease and essential tremor or drug-induced parkinsonism is not possible on clinical grounds. The test cannot distinguish between Parkinson disease and Parkinson-plus conditions. Recent efforts to develop specific biomarkers for Parkinson disease are underway and include assays to measure α-synuclein in cerebral spinal fluid and other biofluids, functional fluorodeoxyglucose PET imaging, and transcranial ultrasonography of the substantia nigra. The clinical utility of these methods remains unclear."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_nr_t33"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_1_3",
"title":{
"__html":"Depression and Fall Screening"
},
"titleNode":{
"type":"section-title",
"hlId":"5c152e",
"children":[
"Depression and Fall Screening"
]
},
"children":[
{
"type":"p",
"hlId":"60c961",
"children":[
"All patients with Parkinson disease should be screened for depression and be assessed for fall risk. Depression and anxiety are common nonmotor symptoms of Parkinson disease and can be detected by using common clinical mood and anxiety scales. Treatments include psychotherapy, antidepressants (excluding antipsychotic agents), and dopaminergic medications (when mood symptoms correlate with motor symptoms). Depression should be distinguished from apathy, a state of reduced motivation and goal-directed behavior that is not associated with sad mood and emotional distress."
]
},
{
"type":"p",
"hlId":"d08da2",
"children":[
"Falls in Parkinson disease may be related to postural imbalance, impaired stepping, freezing of gait, or orthostatic hypotension. Detection of risk factors for falling and implementation of a multidisciplinary management approach—including medications, therapy, supportive devices, and education—can reduce morbidity and costs related to falls. Postural stability can be best assessed by the pull test, in which an examiner throws the patient off balance by pulling backward on the shoulders. A positive test, characterized by toppling into examiner's arms or taking more than two corrective steps, is the most reliable predictor of a risk of backward falls."
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_1_4",
"title":{
"__html":"Treatment of Parkinson Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"75b803",
"children":[
"Treatment of Parkinson Disease"
]
},
"children":[
{
"type":"p",
"hlId":"b1746f",
"children":[
"Currently, no medication with established efficacy is available to slow the progression of Parkinson disease. Rigorous daily exercise can improve the quality of gait and balance and also may provide disease-modifying benefits."
]
},
{
"type":"p",
"hlId":"2b00ee",
"children":[
"Symptomatic treatments include medications ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t34",
"wrapId":"5",
"children":[
"Table 34"
]
}
]
},
")"
]
},
", surgical therapy, and supportive measures. Dopaminergic medications (various formulations of the dopamine precursor levodopa, pramipexole, ropinirole, and rotigotine) are the mainstay in the treatment of motor symptoms. Several other medications can supplement the dopaminergic agents and help reduce the medication-induced complications that may emerge over time as Parkinson disease progresses."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_a_nr_t34"
]
},
{
"type":"p",
"hlId":"767883",
"children":[
"The American Academy of Neurology recommends levodopa as the initial preferred therapy for motor symptoms of early Parkinson disease. Dopamine agonists, such as pramipexole and ropinirole, may be prescribed as the initial dopaminergic therapy to improve motor symptoms in selected patients younger than 60 years who are at higher risk for dyskinesia. Patients taking dopamine agonists should be warned about impulse control disorder, which manifests as a tendency to engage in out-of-character impulsive behaviors, such as excessive gambling, overspending, and hypersexuality. Other adverse effects include sleep attacks, dependent edema, nausea, hallucinations, and confusion."
]
},
{
"type":"p",
"hlId":"3c94bf",
"children":[
"Eventually, all patients with Parkinson disease will require levodopa. Carbidopa, a peripheral decarboxylase inhibitor, blocks the adverse effects of levodopa outside the brain and is used in combination with levodopa. In patients who experience severe peripheral adverse effects of levodopa, such as nausea or orthostatic hypotension, higher doses of carbidopa may alleviate these symptoms."
]
},
{
"type":"p",
"hlId":"2ef2ca",
"children":[
"As many as 50% of patients may develop motor fluctuations after few years of treatment with levodopa. Motor fluctuations include the “wearing-off” phenomenon (loss of the beneficial effect of the medication before the next dose is administered), “sudden off” state (unrelated to timing of the medication), and “early morning off” state. Levodopa-induced dyskinesias may emerge as a result of hypersensitization of dopamine receptors and manifest as involuntary choreiform movements during peak doses of levodopa."
]
},
{
"type":"p",
"hlId":"f31521",
"children":[
"Several formulations of levodopa are commercially available, including oral immediate-release, extended-release, and rapidly disintegrating formulations; an enteral gel infusion and an inhaled formulation also have recently become available (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t34",
"wrapId":"6",
"children":[
"Table 34"
]
}
]
},
")"
]
},
". Immediate-release formulations of levodopa should be prescribed initially in preference to other levodopa formulations. The immediate-release formulations of levodopa have a rapid peak dose effect that many patients find helpful. The newer extended-release formulations may provide a more sustained control of symptoms throughout the day, which can prove beneficial by reducing any wearing off between doses. Wearing off also can be lessened by frequent dosing of levodopa and by the addition of dopamine agonists, catechol-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"O"
]
},
"-methyltransferase inhibitors, or monamine oxidase B inhibitors. Inhaled levodopa can be used as rescue therapy in patients who experience sudden “off” symptoms. Amantadine can be added to the treatment regimen to prevent dyskinesia. Anticholinergic medications also can be added to provide additional benefit in patients with prominent tremor or dystonia but should be avoided in older patients with dementia."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_a_nr_t34"
]
},
{
"type":"p",
"hlId":"7caacb",
"children":[
"Medication-induced psychosis, especially visual hallucinations, also can occur with use of dopaminergic medications. Uncontrolled psychosis is a major risk factor for nursing home placement and contributes to increased mortality in Parkinson disease. Treatment strategies include addressing any systemic trigger, simplifying the medication regimen (including removal of non-levodopa medications and decreasing the levodopa dosage), and, if needed, using certain antipsychotic agents. Pimavanserin, a selective serotonin 5-HT2b receptor inverse agonist, is the only FDA-approved medication for Parkinson psychosis; quetiapine and clozapine also are often used as less expensive, albeit off-label, options."
]
},
{
"type":"p",
"hlId":"dffdef",
"children":[
"Deep brain stimulation (DBS) is a surgical therapy that involves the delivery of electrical stimulation to key brain targets, such as the subthalamic nucleus and the globus pallidus interna. This mode of treatment is indicated for patients who continue to benefit from levodopa but experience motor fluctuations or have a refractory tremor. An algorithm for the treatment of Parkinson disease and the selection of appropriate candidates for DBS surgery is shown in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f22",
"wrapId":"7",
"children":[
"Figure 22"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_a_nr_f22"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"f0de53",
"children":[
"The diagnosis of Parkinson disease requires the presence of bradykinesia and at least one of the other cardinal features of the disorder (tremor at rest, cogwheel rigidity, and gait or balance impairment) and the absence of red flags for atypical forms of parkinsonism."
]
},
{
"type":"keypoint",
"hlId":"cf8d3e",
"hvc":true,
"children":[
"In Parkinson disease, a dopamine transporter single–photon emission CT scan of the brain is unnecessary except to differentiate between Parkinson disease and essential tremor or drug-induced parkinsonism if the distinction cannot be made on clinical grounds."
]
},
{
"type":"keypoint",
"hlId":"efaae9",
"hvc":true,
"children":[
"Detection of risk factors for falling and implementation of a multidisciplinary management approach—including medications, therapy, supportive devices, and education—can reduce morbidity and costs related to falls; a positive pull test is the most reliable predictor of a risk of backward falls in Parkinson disease."
]
},
{
"type":"keypoint",
"hlId":"bc6e84",
"children":[
"Levodopa is the initial preferred therapy for motor symptoms of early Parkinson; dopamine agonists, such as pramipexole and ropinirole, may be prescribed as the initial dopaminergic therapy to improve motor symptoms in selected patients younger than 60 years who are at higher risk for dyskinesia."
]
},
{
"type":"keypoint",
"hlId":"cb77be",
"children":[
"Deep brain stimulation is indicated for patients who continue to benefit from levodopa but experience severe motor fluctuations or have a refractory tremor."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_2",
"title":{
"__html":"Parkinson-Plus Syndromes"
},
"titleNode":{
"type":"section-title",
"hlId":"00c832",
"children":[
"Parkinson-Plus Syndromes"
]
},
"children":[
{
"type":"p",
"hlId":"763f14",
"children":[
"Parkinson-plus syndromes typically present with a combination of parkinsonism and additional features that are atypical for idiopathic Parkinson disease. These conditions often are more rapidly progressive than Parkinson disease and are refractory to standard therapies, particularly levodopa. The primary syndromes include progressive supranuclear palsy, multiple system atrophy (formerly Shy-Drager syndrome), and corticobasal degeneration. Patients with progressive supranuclear palsy have parkinsonism, axial rigidity, prominent postural instability with early falls, impairment in both ocular range of movement and saccades (very fast jumps from one eye position to another, particularly in the vertical direction), facial dystonia, dysphagia, dysarthria (see ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v02",
"wrapId":"8",
"children":[
"Video 2"
]
}
]
},
"), and subcortical dementia. Multiple system atrophy presents with a combination of parkinsonism, ataxia, and severe dysautonomia (orthostatic hypotension and urinary dysfunction) and is also associated with early falls. Corticobasal degeneration often presents with markedly asymmetric parkinsonism and frequently is associated with dystonia, myoclonus, cortical sensory deficits, cognitive deficits, aphasia, and apraxia (impaired motor planning)."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_a_nr_v02"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"9e10ef",
"children":[
"Parkinson-plus syndromes often are more rapidly progressive than Parkinson disease, have additional features that are atypical for idiopathic Parkinson disease, and are less responsive to standard antiparkinsonian therapies, particularly levodopa."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_2_3",
"title":{
"__html":"Drug-Induced Parkinsonism"
},
"titleNode":{
"type":"section-title",
"hlId":"1fa0a0",
"children":[
"Drug-Induced Parkinsonism"
]
},
"children":[
{
"type":"p",
"hlId":"12857c",
"children":[
"A number of drugs, especially dopamine receptor–blocking antipsychotic agents, can cause parkinsonism ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t35",
"wrapId":"9",
"children":[
"Table 35"
]
}
]
},
")"
]
},
". Drug-induced parkinsonism is symmetric, lacks nonmotor features, and is reversible after removal of the causative agent. In 10% of patients, parkinsonism persists more than 6 months after removal of the offending agent, which represents the unmasking of a preclinical neurodegenerative disease. Several other extrapyramidal complications of dopamine-receptor blockers have also been described ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t36",
"wrapId":"9",
"children":[
"Table 36"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_a_nr_t35",
"mk19_a_nr_t36"
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3",
"title":{
"__html":"Hyperkinetic Movement Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"2760fb",
"children":[
"Hyperkinetic Movement Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s6_3_1",
"title":{
"__html":"Essential Tremor"
},
"titleNode":{
"type":"section-title",
"hlId":"1b640f",
"children":[
"Essential Tremor"
]
},
"children":[
{
"type":"p",
"hlId":"6f6e8e",
"children":[
"Tremor is an oscillatory movement of a body part that is classified by its presence at rest or with action ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t37",
"wrapId":"10",
"children":[
"Table 37"
]
}
]
},
")"
]
},
". Essential tremor is the most common movement disorder (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v12",
"wrapId":"10",
"children":[
"Video 12"
]
}
]
},
"). It is defined as an isolated tremor syndrome of at least 3 years' duration characterized by action tremor in the upper extremities. This type of tremor also can involve the voice, head, or legs. Common features include a positive family history (50% of patients), slow progression, and onset in either adolescence or middle age. The tremor may be alleviated by alcohol and may be aggravated by stress, illness, fatigue, or the use of stimulants. A minority of affected patients experience substantial progression, leading to marked disability. If essential tremor presents with mild additional neurologic signs, such as mild ataxia or isolated tremor at rest without bradykinesia, it would be classified as “essential tremor plus.” The differential diagnosis includes enhanced physiologic tremor, which is a low-amplitude tremor that is unnoticeable in most people but may become prominent because of physical and psychological stressors, medications, caffeine, or thyrotoxicosis. Assessment of any form of action tremor should include thyroid and renal function studies, liver chemistries, measurement of serum electrolytes, and a review of medications ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t38",
"wrapId":"10",
"children":[
"Table 38"
]
}
]
},
")"
]
},
". Patients younger than 40 years should undergo screening for Wilson disease with serum ceruloplasmin and 24-hour urine copper measurements. Slit-lamp ophthalmologic examination for Kayser-Fleischer rings ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f23",
"wrapId":"10",
"children":[
"Figure 23"
]
}
]
},
")"
]
},
" also should be considered. Other rare causes of action tremor include dystonic tremor, rubral tremor, and orthostatic tremor (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t37",
"wrapId":"10",
"children":[
"Table 37"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_a_nr_t37",
"mk19_a_nr_v12",
"mk19_a_nr_t38",
"mk19_a_nr_f23"
]
},
{
"type":"p",
"hlId":"338d17",
"children":[
"The treatment of essential tremor is symptomatic. Weighted utensils and wrist weights can help reduce tremor amplitude during feeding. The most effective pharmacologic treatments for essential tremor are propranolol, primidone, and topiramate. Additional second-line options include atenolol, sotalol, clonazepam, gabapentin, and nimodipine. Botulinum toxin injection can help with some tremors, especially those involving the neck and voice, but its benefit for limb tremor is limited by local weakness. Medication-refractory tremor can be effectively treated by targeting the ventral intermediate nucleus of the thalamus with DBS (unilaterally or bilaterally) or focused ultrasound thalamotomy (unilaterally)."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ba22e6",
"children":[
"Essential tremor is the most common movement disorder and often presents with an isolated bilateral upper extremity action tremor; common features include a positive family history, alleviation by alcohol, slow progression, and onset in either adolescence or middle age."
]
},
{
"type":"keypoint",
"hlId":"6e8293",
"children":[
"The treatment of essential tremor is symptomatic; the most effective pharmacologic agents are propranolol, primidone, and topiramate."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_2",
"title":{
"__html":"Dystonia"
},
"titleNode":{
"type":"section-title",
"hlId":"769e68",
"children":[
"Dystonia"
]
},
"children":[
{
"type":"p",
"hlId":"3412fe",
"children":[
"Dystonia involves sustained or intermittent muscle contractions leading to repetitive twisting and posturing movements of various body parts. Dystonias are classified according to age of onset, body distribution, temporal pattern, associated features, and cause ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t39",
"wrapId":"11",
"children":[
"Table 39"
]
}
]
},
")"
]
},
". Dystonia is distinguished from chorea by the nonrandom and directional nature of its movements and from myoclonus by its slower speed. Generalized dystonias involve multiple body parts, including the trunk, whereas focal and segmental dystonias have a more restricted distribution and usually spare the lower extremities. Hemidystonia is limited to one side of the body. Generalized dystonias often start at a young age (<25 years) and have inherited, metabolic, or vascular causes. The most common type of generalized dystonia involves mutation in the dystonia 1 gene (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"DYT1"
]
},
"). Patients with primary generalized dystonia should be challenged by a short trial of levodopa to screen for dopa-responsive dystonia, a rare but treatable cause of generalized dystonia. Young adults with progressive dystonia should be screened for Wilson disease, especially in the presence of other associated findings (such as tremor and parkinsonism)."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_a_nr_t39"
]
},
{
"type":"p",
"hlId":"feff2c",
"children":[
"Focal adult-onset dystonias are often sporadic and include cervical dystonia (spasmodic torticollis), eyelid dystonia (blepharospasm), vocal cord spasmodic dysphonia, and task-specific hand dystonia (writer's cramp). Cervical dystonia often involves involuntary deviation of the head from the midline, an irregular head tremor that lessens with positional changes (null point), and transient improvement of movements by specific sensory tricks (such as gently touching the face with the hand). Treatment includes anticholinergic agents, benzodiazepines, baclofen, levodopa, injection with botulinum toxin, and, in refractory cases, DBS therapy."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"c4b283",
"children":[
"Dystonia involves sustained or intermittent muscle contractions leading to stereotyped and directional twisting and posturing movements of various body parts."
]
},
{
"type":"keypoint",
"hlId":"2b39cf",
"children":[
"Treatment of cervical dystonia includes anticholinergic agents, benzodiazepines, baclofen, levodopa, and injection with botulinum toxin."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_3",
"title":{
"__html":"Choreiform Disorders and Huntington Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"55bdd0",
"children":[
"Choreiform Disorders and Huntington Disease"
]
},
"children":[
{
"type":"p",
"hlId":"e6f558",
"children":[
"Chorea manifests as random, nonrepetitive, flowing dance-like movements (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_a_nr_v13",
"wrapId":"12",
"children":[
"Video 13"
]
}
]
},
") and can be caused by medications, endocrine derangement, streptococcal infection (as in Sydenham chorea in rheumatic fever), autoimmune disease, pregnancy and neurodegenerative disorders involving the basal ganglia ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t40",
"wrapId":"12",
"children":[
"Table 40"
]
}
]
},
")"
]
},
". Patients with acute and subacute onset of chorea should be assessed for reversible acquired causes, whereas a more insidious onset is typical of neurodegenerative disorders. The most common neurodegenerative cause of generalized chorea is Huntington disease, an autosomal dominant condition marked by symptoms of progressive parkinsonism, gait impairment, impulsiveness, psychiatric disease, dementia, and premature death. Symptomatic treatments of chorea include the dopamine depleters valbenazine, deutetrabenazine, and tetrabenazine; antipsychotic agents; clonazepam; and antiepileptic drugs."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_a_nr_v13",
"mk19_a_nr_t40"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d9a6e2",
"children":[
"Huntington disease is an autosomal dominant condition marked by symptoms of progressive parkinsonism, gait impairment, impulsiveness, psychiatric disease, and dementia."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_4",
"title":{
"__html":"Myoclonus"
},
"titleNode":{
"type":"section-title",
"hlId":"81308f",
"children":[
"Myoclonus"
]
},
"children":[
{
"type":"p",
"hlId":"19311a",
"children":[
"Myoclonus is a brief, shock-like, jerky movement that can be physiologic (hiccups, hypnic jerks at sleep onset) or pathologic (caused by medications, toxins, or systemic or central disease) ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t41",
"wrapId":"13",
"children":[
"Table 41"
]
}
]
},
")"
]
},
". Myoclonus can originate from various parts of the nervous system, including the cortex, subcortical structures, the spine, or peripheral nerves. Cortical myoclonus is often epileptic. Negative myoclonus is caused by sudden loss of muscle tone, as seen in asterixis and in the legs after hypoxia (Lance-Adams syndrome). Management of myoclonus includes addressing the underlying systemic or toxic causes and administering antimyoclonic agents, such as clonazepam or valproic acid."
]
},
{
"type":"inline-wrap",
"wrapId":"13",
"contentIds":[
"mk19_a_nr_t41"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"084155",
"children":[
"Treatment of myoclonus includes addressing the underlying systemic or toxic causes and administering antimyoclonic agents, such as clonazepam or valproic acid."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_5",
"title":{
"__html":"Tic Disorders and Tourette Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"cac5f8",
"children":[
"Tic Disorders and Tourette Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"f9b30a",
"children":[
"Tics are stereotyped, rapid movements interrupting the flow of normal movements. Tics may provide transient relief in response to premonitory unconformable sensations and are at least partially suppressible. Tics usually start during childhood and subside during adulthood, but they may persist in a minority of those affected. Waxing and waning of tics over time is common."
]
},
{
"type":"p",
"hlId":"e85c50",
"children":[
"Tourette syndrome is characterized by childhood-onset motor and phonic tics with a duration of at least 1 year. Phonic tics include vocalizations and, less commonly, echolalia (repetition of others' words) and coprolalia (utterance of obscenities). Tic severity may range from minimal to very disruptive. Common comorbidities include attention-deficit hyperactivity disorder, obsessive compulsive disorder, and mood disorders. Diagnosis is clinical. Treatment options include reassurance (in mild disease), cognitive behavioral therapy, and addressing psychiatric comorbidities. Anti-tic medications are indicated when tics interfere with daily functioning, education, or work. First-line treatments include clonidine, guanfacine, topiramate, levetiracetam, and tetrabenazine. In refractory disease, antipsychotic agents, injections with botulinum toxin, and DBS therapy may be considered."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7158f8",
"children":[
"Tics are stereotyped, rapid, partially suppressible movements interrupting the flow of normal movements and may provide transient relief in response to premonitory unconformable sensations."
]
},
{
"type":"keypoint",
"hlId":"186cd4",
"children":[
"Tourette syndrome is characterized by childhood-onset motor and phonic tics with a duration of at least 1 year."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_6",
"title":{
"__html":"Restless Legs Syndrome and Sleep-Related Movement Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"5ec281",
"children":[
"Restless Legs Syndrome and Sleep-Related Movement Disorders"
]
},
"children":[
{
"type":"p",
"hlId":"e6d7ee",
"children":[
"Restless legs syndrome (RLS) is a common movement disorder characterized by an urge to move the legs. Patients report an uncomfortable sensation that is worse at rest and at night and is transiently relieved by movement. RLS can interfere with falling or staying asleep. Patients with RLS should be screened for iron deficiency because iron supplementation in the presence of low-normal ferritin levels (15-75 ng/mL [15-75 μg/L]) may resolve the symptoms. Supplementation with intravenous ferric carboxymaltose is likely efficacious in idiopathic RLS, whereas efficacy of oral iron supplementation remains unproven. Other risk factors for RLS include uremia, sleep apnea, pregnancy, and certain medications (including selective serotonin reuptake inhibitors, antipsychotic agents, and stimulant drugs). Nonpharmacologic measures include improvement of sleep hygiene, exercise, and the use of a vibrational device. First-line pharmacologic treatments include the dopamine agonists pramipexole, ropinirole, and rotigotine. Additional options include levodopa, pergolide, gabapentin, gabapentin enacarbil, pregabalin, and opioid agonists (such as prolonged-release oxycodone-naloxone and methadone). Chronic use of dopamine agonists, however effective, may lead to either augmentation (that is, symptoms start earlier in the day) or rebound (that is, symptoms return with greater severity after the medication wears off). Use of long-acting formulations can lessen both complications. Nondopaminergic medications are another alternative in patients with augmentation. Opioids are typically restricted to patients with severe symptoms recalcitrant to other therapies. Physicians prescribing opioids for RLS should be adherent to the Centers for Disease Control and Prevention guideline for prescribing opioids (see ",
{
"type":"cross-reference",
"target":"mk19_a_gm_s5_3_2_2",
"children":[
"MKSAP 19 General Internal Medicine 1"
]
},
")."
]
},
{
"type":"p",
"hlId":"fcef39",
"children":[
"Periodic limb movements of sleep are brief triple flexion (ankle, knee, hip) movements of the legs that repeat in 20-second cycles during sleep. This disorder is very common and can occur independently of or be associated with RLS, sleep-disordered breathing, or narcolepsy. The diagnosis is made by using polysomnography. Treatment of this disorder is only required if it causes marked sleep fragmentation."
]
},
{
"type":"p",
"hlId":"6eac0d",
"children":[
"RBD is caused by loss of normal paralysis during the REM phase of sleep, leading to dream-enactment behavior. Patients with this condition tend to shout, kick, punch, and jump while dreaming. History is often obtained from a bed partner because patients do not recall their dream-enactment behavior. Diagnosis can be confirmed by polysomnography. Differential diagnosis includes nocturnal epilepsy, and non-REM parasomnias. Isolated RBD has a high predictive value as a specific and early marker of future development of synuclein-related neurodegeneration, such as Parkinson disease, multiple system atrophy, or dementia with Lewy bodies. Patients with RBD are an appropriate target for potential disease-modifying interventions aimed at prevention of these disorders. RBD responds well to melatonin and clonazepam."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"b97e63",
"children":[
"Patients with restless legs syndrome should be screened for iron deficiency because iron supplementation in the presence of low-normal ferritin levels may resolve the symptoms."
]
},
{
"type":"keypoint",
"hlId":"d1d835",
"children":[
"The diagnosis of periodic limb movements of sleep is made by using polysomnography; treatment is only required if the disorder causes marked sleep fragmentation."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_7",
"title":{
"__html":"Other Drug-Induced Movements"
},
"titleNode":{
"type":"section-title",
"hlId":"5aa8d6",
"children":[
"Other Drug-Induced Movements"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s6_3_7_1",
"title":{
"__html":"Tardive Dyskinesia"
},
"titleNode":{
"type":"section-title",
"hlId":"ff5997",
"children":[
"Tardive Dyskinesia"
]
},
"children":[
{
"type":"p",
"hlId":"d5aa38",
"children":[
"Tardive dyskinesia is an extrapyramidal complication of dopamine receptor–blocking medications (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t36",
"wrapId":"14",
"children":[
"Table 36"
]
}
]
},
")"
]
},
". It is associated with characteristic choreiform and dystonic craniofacial movements, which often involve other body parts, such as the neck and trunk. Other movements, such as tremor, myoclonus, and akathisia (restlessness) also can be part of a tardive syndrome. Treatment involves removal of the offending medication. Symptoms of dyskinesia, however, can take months to resolve or become permanent. Longer duration and higher doses of medication exposure, older age, and female gender increase the risk of irreversibility. Risk is highest with typical antipsychotic agents, but many atypical antipsychotic and antiemetic agents also can cause tardive dyskinesia. All patients receiving these agents must be warned about the risk of this complication. Treatment includes the monoamine depleters valbenazine, deutetrabenazine, and tetrabenazine. Other options are amantadine, clonazepam, and, in refractory disease, DBS."
]
},
{
"type":"inline-wrap",
"wrapId":"14",
"contentIds":[
"mk19_a_nr_t36"
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_3_7_2",
"title":{
"__html":"Neuroleptic Malignant Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"678831",
"children":[
"Neuroleptic Malignant Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"7eeaef",
"children":[
"Neuroleptic malignant syndrome is an acute life-threatening disorder caused by an idiosyncratic reaction to therapeutic doses of dopamine-blocking agents. Affected patients present with fever, rhabdomyolysis, altered mental status, rigidity, and dystonia. The creatine kinase level often is remarkably elevated. The most effective treatment is removal of the offending agent and supportive management. Treatment options include dopamine agonists and the muscle relaxant dantrolene, although there is only weak evidence supporting their effectiveness. Mortality may be as high as 10%. Patients who have dementia with Lewy bodies are particularly susceptible to neuroleptic malignant syndrome. A similar condition, parkinsonism-hyperpyrexia syndrome, can be triggered by rapid withdrawal of dopaminergic medication in patients with Parkinson disease, including when medications are stopped in the hospital before surgery. See ",
{
"type":"cross-reference",
"target":"mk19_b_pm_s13_2_3",
"children":[
"MKSAP 19 Pulmonary and Critical Care Medicine"
]
},
" for more information about neuroleptic malignant syndrome."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"5882db",
"children":[
"Tardive dyskinesia is an extrapyramidal complication of dopamine receptor–blocking medications characterized by choreiform and dystonic craniofacial movements; symptoms can take months to resolve or become permanent."
]
},
{
"type":"keypoint",
"hlId":"8a05a4",
"children":[
"Neuroleptic malignant syndrome is an acute life-threatening disorder caused by exposure to therapeutic doses of dopamine-blocking agents; it presents with fever, rhabdomyolysis, altered mental status, rigidity, and dystonia."
]
}
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s6_4",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nat Rev Dis Primers. 2018;4(1):25. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30237473",
"target":"_blank"
},
"children":[
"PMID: 30237473"
]
},
" doi:10.1038/s41572-018-0023-6."
]
},
{
"type":"reference",
"children":[
"Feinstein E, Walker R. An update on the treatment of chorea. Curr Treat Options Neurol. 2018 Sep 25;20(10):44. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30255459",
"target":"_blank"
},
"children":[
"PMID: 30255459"
]
},
" doi:10.1007/s11940-018-0529-y."
]
},
{
"type":"reference",
"children":[
"Haubenberger D, Hallett M. Essential tremor. N Engl J Med. 2018 May 10;378(19):1802-10. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29742376",
"target":"_blank"
},
"children":[
"PMID: 29742376"
]
},
" doi:10.1056/NEJMcp1707928."
]
},
{
"type":"reference",
"children":[
"Homayoun H. Parkinson disease. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/AITC201809040",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2018 Sep 4;169(5):ITC33-48. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30178019",
"target":"_blank"
},
"children":[
"PMID: 30178019"
]
},
"."
]
},
{
"type":"reference",
"children":[
"Malek N, Baker MR. Common toxidromes in movement disorder neurology. Postgrad Med J. 2017 Jun;93(1100):326-32. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28546460",
"target":"_blank"
},
"children":[
"PMID: 28546460"
]
},
" doi:10.1136/postgradmedj-2016-134254."
]
},
{
"type":"reference",
"children":[
"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct;30(12):1591-601. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26474316",
"target":"_blank"
},
"children":[
"PMID: 26474316"
]
},
". doi:10.1002/mds.26424."
]
},
{
"type":"reference",
"children":[
"Pringsheim T, Day GS, Smith DB, et al; Guideline Subcommittee of the AAN. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: A report of the AAN Guideline Subcommittee. Neurology. 2021;97:942-957. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34782410",
"target":"_blank"
},
"children":[
"PMID: 34782410"
]
},
" doi:10.1212/WNL.0000000000012868"
]
},
{
"type":"reference",
"children":[
"Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):896-906. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31061208",
"target":"_blank"
},
"children":[
"PMID: 31061208"
]
},
" doi:10.1212/WNL.0000000000007466."
]
},
{
"type":"reference",
"children":[
"Rajan S, Kaas B, Moukheiber E. Movement disorders emergencies. Semin Neurol. 2019 Feb;39(1):125-36. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30743298",
"target":"_blank"
},
"children":[
"PMID: 30743298"
]
},
" doi:10.1055/s-0038-1677050."
]
},
{
"type":"reference",
"children":[
"Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence-based medicine review. Mov Disord. 2019 Feb;34(2):180-98. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30653247",
"target":"_blank"
},
"children":[
"PMID: 30653247"
]
},
" doi:10.1002/mds.27602."
]
},
{
"type":"reference",
"children":[
"Winkelmann J, Allen RP, Högl B, et al. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§. Mov Disord. 2018;33:1077-1091. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29756335",
"target":"_blank"
},
"children":[
"PMID: 29756335"
]
},
" doi:10.1002/mds.27260"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_nr_t31":{
"id":"mk19_a_nr_t31",
"number":31,
"bookId":"nr",
"title":{
"__html":"Classification of Movement Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b46096",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 31. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t31"
}
]
},
"Classification of Movement Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"87d912",
"class":"col hd l",
"children":[
"Movement Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7962dd",
"class":"col hd l",
"children":[
"Clinical Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff7c0f",
"class":"col hd l",
"children":[
"Examples"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d21d50",
"class":"col hd l",
"children":[
"Hypokinetic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e39b35",
"class":"cell txt l",
"children":[
"Parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"036a82",
"class":"cell txt l",
"children":[
"Cardinal features: bradykinesia/hypokinesia, rigidity, rest tremor, postural instability"
]
},
" ",
{
"type":"p",
"hlId":"1376b8",
"class":"cell txt l",
"children":[
"Additional features: freezing gait, stooped posture, masked face, hypophonia, micrographia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"df0268",
"class":"cell txt l",
"children":[
"Parkinson disease, Parkinson-plus syndromes, dementia with Lewy bodies, vascular parkinsonism, hydrocephalus, medication-induced parkinsonism, Wilson disease, young-onset Huntington disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"db5b2b",
"class":"col hd l",
"children":[
"Hyperkinetic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"68e746",
"class":"cell txt l",
"children":[
"Tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9a12b",
"class":"cell txt l",
"children":[
"Rhythmic oscillations of a body part, can occur at rest or with action (including postural or kinetic)"
]
},
" ",
{
"type":"p",
"hlId":"343462",
"class":"cell txt l",
"children":[
"Intention tremor is characterized by marked increase in tremor amplitude near target"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1603eb",
"class":"cell txt l",
"children":[
"Rest tremor: parkinsonism"
]
},
" ",
{
"type":"p",
"hlId":"922f64",
"class":"cell txt l",
"children":[
"Postural and kinetic tremor: essential tremor, enhanced physiologic tremor"
]
},
" ",
{
"type":"p",
"hlId":"64babe",
"class":"cell txt l",
"children":[
"Intention tremor: cerebellar"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"769e68",
"class":"cell txt l",
"children":[
"Dystonia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6da656",
"class":"cell txt l",
"children":[
"Sustained or intermittent, stereotyped, and directional twisting and posturing movements of various body parts; can be associated with sensory trick (“geste antagoniste” or movement or touch that interrupts dystonia)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"184a11",
"class":"cell txt l",
"children":[
"Primary: primary generalized dystonia (DYT1), dopa-responsive dystonia, torticollis, blepharospasm, writer's cramp"
]
},
" ",
{
"type":"p",
"hlId":"6a9935",
"class":"cell txt l",
"children":[
"Secondary: basal ganglia lesion, anoxic injury, postencephalitic, cerebral palsy, medications"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aae7b1",
"class":"cell txt l",
"children":[
"Chorea"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea1685",
"class":"cell txt l",
"children":[
"Random, nonrepetitive, quick, unsustained, purposeless movements with a flowing dance-like pattern"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58156e",
"class":"cell txt l",
"children":[
"Huntington disease, neuroacanthocytosis, poststreptococcal (Sydenham chorea), chorea gravidarum, autoimmune, metabolic, vascular, medications"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"687efe",
"class":"cell txt l",
"children":[
"Hemiballismus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"91f830",
"class":"cell txt l",
"children":[
"Unilateral high-amplitude proximal flailing, ballistic, choreiform movements of limbs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fe6013",
"class":"cell txt l",
"children":[
"Lesions of contralateral subthalamic or adjacent parts of basal ganglia (often stroke)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5d3966",
"class":"cell txt l",
"children":[
"Athetosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"abd9b2",
"class":"cell txt l",
"children":[
"Slow convoluted writhing movements of digits and toes"
]
},
" ",
{
"type":"p",
"hlId":"75b683",
"class":"cell txt l",
"children":[
"Pseudoathetosis similar but elicited by eye closure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5ab146",
"class":"cell txt l",
"children":[
"Early-life damage to basal ganglia (hypoxia, kernicterus, vascular event)"
]
},
" ",
{
"type":"p",
"hlId":"e63f21",
"class":"cell txt l",
"children":[
"Pseudoathetosis caused by lesions of proprioceptive pathway"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9c139e",
"class":"cell txt l",
"children":[
"Tic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5e280b",
"class":"cell txt l",
"children":[
"Stereotyped, brief, purposeless, rapid movements that break the flow of normal movements; can be simple or complex, motor or vocal; premonitory sensory urges, suggestibility, and suppressibility"
]
},
" ",
{
"type":"p",
"hlId":"773da1",
"class":"cell txt l",
"children":[
"Stereotypy is a coordinated ritualistic and highly repetitive movement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"42ad9e",
"class":"cell txt l",
"children":[
"Tourette syndrome, autism, developmental delay syndromes, Huntington disease, medications"
]
},
" ",
{
"type":"p",
"hlId":"187caf",
"class":"cell txt l",
"children":[
"Stereotypy can be normal in young children or associated with developmental delay and neurometabolic syndromes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"81308f",
"class":"cell txt l",
"children":[
"Myoclonus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"41a449",
"class":"cell txt l",
"children":[
"Rapid, shock-like, jerky movement of isolated body parts or whole body"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"29001e",
"class":"cell txt l",
"children":[
"Metabolic, medications, infections, autoimmune, myoclonic epilepsies, benign essential myoclonus, corticobasal degeneration, Alzheimer disease, prion disease, sleep-related (hypnic jerks)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59004d",
"class":"cell txt l",
"children":[
"Akathisia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"37d38f",
"class":"cell txt l",
"children":[
"Inner restlessness associated with repetitive movements"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1c329f",
"class":"cell txt l",
"children":[
"Drug-induced, restless legs syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7734e9",
"class":"cell txt l",
"children":[
"Psychogenic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"80277a",
"class":"cell txt l",
"children":[
"Highly variable, inconsistent, distractible, acute onset, episodic, with variable frequency of tremor, with fixed dystonia, with acrobatic uneconomic gait (astasia-abasia)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e668fa",
"class":"cell txt l",
"children":[
"Conversion disorder, malingering"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t32":{
"id":"mk19_a_nr_t32",
"number":32,
"bookId":"nr",
"title":{
"__html":"Nonmotor Symptoms of Parkinson Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"898859",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 32. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t32"
}
]
},
"Nonmotor Symptoms of Parkinson Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3adbdb",
"class":"col hd l",
"children":[
"Category"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"062cf6",
"class":"col hd l",
"children":[
"Nonmotor Symptoms"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"215513",
"class":"cell txt l",
"children":[
"Cognitive"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a4d3db",
"class":"cell txt l",
"children":[
"Bradyphrenia (slow processing), mild subcortical cognitive impairment (slow processing speed, impaired short-term memory, and attention deficits with relative sparing of cortical functions, such as language and declarative memory), dementia possible at advanced stages"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a00cd",
"class":"cell txt l",
"children":[
"Affective and behavioral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"df5021",
"class":"cell txt l",
"children":[
"Primary: depression, anxiety, apathy, pseudobulbar affect (emotional incontinence)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c18d00",
"class":"cell txt l",
"children":[
"Medication-induced: psychosis, impulse control disorder, punding (purposeless stereotyped behavior), dopamine dysregulation syndrome (craving for dopaminergic medications)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"37c06c",
"class":"cell txt l",
"children":[
"Sleep related"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b27eea",
"class":"cell txt l",
"children":[
"Sleep fragmentation, sleep-wake reversal, rapid eye movement sleep behavior disorder, restless legs syndrome, medication-related sedation and sleep attacks, fatigue"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2ac9f",
"class":"cell txt l",
"children":[
"Autonomic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fa193",
"class":"cell txt l",
"children":[
"Constipation, postural hypotension, bladder and sexual dysfunction, sialorrhea, seborrhea, excessive sweating, hyposmia or anosmia (impaired sense of smell)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b3d4d",
"class":"cell txt l",
"children":[
"Musculoskeletal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7baa11",
"class":"cell txt l",
"children":[
"Truncal and cervical stooped posturing, camptocormia (truncal flexion during standing and walking), frozen shoulder, dystonic joint deformities in hands and toes, and fall-related injuries"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1ffc6",
"class":"cell txt l",
"children":[
"Pain related"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f8a072",
"class":"cell txt l",
"children":[
"Painful dystonia, painful rigidity, mechanical pain, central and visceral pain"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t33":{
"id":"mk19_a_nr_t33",
"number":33,
"bookId":"nr",
"title":{
"__html":"Red Flags for Atypical Forms of Parkinsonism"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b29e0b",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 33. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t33"
}
]
},
"Red Flags for Atypical Forms of Parkinsonism"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"227072",
"class":"col hd l",
"children":[
"Red Flags"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"847ec3",
"class":"col hd l",
"children":[
"Likely Alternative Diagnosis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1c74d1",
"class":"cell txt l",
"children":[
"Dysautonomia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fece57",
"class":"cell txt l",
"children":[
"Prominent orthostatic hypotension, urinary incontinence, impotence, inappropriate sweating (mild autonomic deficits can be seen in early Parkinson disease)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14e24f",
"class":"cell txt l",
"children":[
"Multiple system atrophy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e390fd",
"class":"cell txt l",
"children":[
"Abnormal eye movements"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd93c3",
"class":"cell txt l",
"children":[
"Supranuclear vertical gaze palsy, slowness of vertical saccades"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"853175",
"class":"cell txt l",
"children":[
"Progressive supranuclear palsy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f0c66d",
"class":"cell txt l",
"children":[
"Prominent early cognitive impairment"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b457e1",
"class":"cell txt l",
"children":[
"Dementia within first year of onset (mild cognitive impairment common in Parkinson disease; dementia may develop in a notable subgroup of patients in advanced stages)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"366789",
"class":"cell txt l",
"children":[
"Dementia with Lewy bodies but sometimes progressive supranuclear palsy or vascular parkinsonism"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7038f",
"class":"cell txt l",
"children":[
"Visual hallucinations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5e8c48",
"class":"cell txt l",
"children":[
"Early and not provoked by medications (levodopa-induced hallucinations can be seen in Parkinson disease, especially in later stages)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f978f9",
"class":"cell txt l",
"children":[
"Dementia with Lewy bodies"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2fd7ad",
"class":"cell txt l",
"children":[
"Early prominent postural instability and falls"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a725be",
"class":"cell txt l",
"children":[
"Within first year of onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4278e1",
"class":"cell txt l",
"children":[
"Multiple system atrophy, progressive supranuclear palsy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"904e06",
"class":"cell txt l",
"children":[
"Prominent gait ataxia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9cd416",
"class":"cell txt l",
"children":[
"Wide-based gait with variable stepping, with or without additional cerebellar deficits (dysmetria, nystagmus)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14e24f",
"class":"cell txt l",
"children":[
"Multiple system atrophy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3ff95",
"class":"cell txt l",
"children":[
"Symmetric or markedly asymmetric involvement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"707a90",
"class":"cell txt l",
"children":[
"In Parkinson disease, characteristically asymmetric at onset and throughout its course"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c49bd4",
"class":"cell txt l",
"children":[
"Lack of asymmetry indicative of atypical parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4278e1",
"class":"cell txt l",
"children":[
"Multiple system atrophy, progressive supranuclear palsy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21fb9f",
"class":"cell txt l",
"children":[
"Very severe asymmetric involvement, possibly suggestive of corticobasal degeneration, and usually associated with severe fixed dystonic posturing, myoclonus, apraxia, and sensory cortical deficits"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3747e2",
"class":"cell txt l",
"children":[
"Corticobasal degeneration"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a82ca",
"class":"cell txt l",
"children":[
"Rapid onset and step-wise deterioration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b53c6a",
"class":"cell txt l",
"children":[
"More suggestive of vascular parkinsonism (Parkinson disease is associated with slow onset and gradual course)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14505e",
"class":"cell txt l",
"children":[
"Vascular parkinsonism"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"430638",
"class":"cell txt l",
"children":[
"Lack of response to levodopa",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b55bf",
"class":"cell txt l",
"children":[
"Most important red flag of atypical parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c505e1",
"class":"cell txt l",
"children":[
"Multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, vascular parkinsonism"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Must not be secondary to adverse effects or insufficient dosing of medication."
]
]
},
"mk19_a_nr_t34":{
"id":"mk19_a_nr_t34",
"number":34,
"bookId":"nr",
"title":{
"__html":"Medications for Parkinson Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"73dfa9",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 34. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t34"
}
]
},
"Medications for Parkinson Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bd813",
"class":"col hd l",
"children":[
"Class"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"645024",
"class":"col hd l",
"children":[
"Forms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"61dfea",
"class":"col hd l",
"children":[
"Clinical Indication"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa0acd",
"class":"cell txt l",
"children":[
"Dopamine precursor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fed966",
"class":"cell txt l",
"children":[
"Levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22ef90",
"class":"cell txt l",
"children":[
"Most effective treatment for motor deficits"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"083960",
"class":"cell txt l",
"children":[
"Initial preferred therapy for motor symptoms in early Parkinson disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"092c18",
"class":"cell txt l",
"children":[
"Second-line treatment in younger patients who have failed dopamine agonists"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1dfec3",
"class":"cell txt li",
"children":[
"Oral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"840fc6",
"class":"cell txt l",
"children":[
"Immediate-release levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a755e",
"class":"cell txt l",
"children":[
"Recommended initial levodopa formulation. Maintenance therapy during waking hours, peak effect provides good “on”-time benefit"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"34daa8",
"class":"cell txt l",
"children":[
"Continued-release levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b8766f",
"class":"cell txt l",
"children":[
"Nighttime therapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75372d",
"class":"cell txt l",
"children":[
"Extended-release levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ef1da4",
"class":"cell txt l",
"children":[
"Maintenance therapy if immediate-release formulation causes motor fluctuations and dyskinesia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"210373",
"class":"cell txt l",
"children":[
"Orally disintegrating levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24ccfc",
"class":"cell txt l",
"children":[
"Rapid relief of sudden “off” state"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44cb66",
"class":"cell txt li",
"children":[
"Inhaled"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"757983",
"class":"cell txt l",
"children":[
"Inhaled levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24ccfc",
"class":"cell txt l",
"children":[
"Rapid relief of sudden “off” state"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"559225",
"class":"cell txt li",
"children":[
"Enteral gel"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd5bc",
"class":"cell txt l",
"children":[
"Enteral levodopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"626b85",
"class":"cell txt l",
"children":[
"Maintenance therapy in advanced Parkinson disease associated with severe motor complications of immediate-release levodopa, provides sustained levodopa release, can cause a higher rate of gastrointestinal complications"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6bb5c4",
"class":"cell txt l",
"children":[
"Decarboxylase inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea9785",
"class":"cell txt l",
"children":[
"Carbidopa, benserazide",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"799138",
"class":"cell txt l",
"children":[
"Suppression of peripheral adverse effects of levodopa"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5f779",
"class":"cell txt l",
"children":[
"Dopamine agonists"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1dfec3",
"class":"cell txt li",
"children":[
"Oral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"392cd1",
"class":"cell txt l",
"children":[
"Pramipexole, ropinirole, cabergoline",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e8dc84",
"class":"cell txt l",
"children":[
"May be considered as initial therapy in younger patients (age <60 y), adjuvant therapy to limit total dose of levodopa, treatment to counteract wearing-off phenomenon"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"156e10",
"class":"cell txt li",
"children":[
"Patch"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747fec",
"class":"cell txt l",
"children":[
"Rotigotine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a3cc4",
"class":"cell txt l",
"children":[
"Similar to oral forms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1660b5",
"class":"cell txt li",
"children":[
"Subcutaneous injection"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2cd102",
"class":"cell txt l",
"children":[
"Apomorphine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f56c1",
"class":"cell txt l",
"children":[
"Rapid relief of sudden “off”-time"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b7e35",
"class":"cell txt l",
"children":[
"Catechol-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"O"
]
},
"-methyltransferase inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"681035",
"class":"cell txt l",
"children":[
"Entacapone (often used), tolcapone (hepatic toxicity)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c793e1",
"class":"cell txt l",
"children":[
"Counteracting of wearing-off phenomenon, prolongation of levodopa effect"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f6871",
"class":"cell txt l",
"children":[
"Monoamine oxidase type B inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"db36b3",
"class":"cell txt l",
"children":[
"Selegiline, rasagiline, safinamide"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff0022",
"class":"cell txt l",
"children":[
"Initial therapy in mild cases, potentiation of levodopa effect, tremor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f91fd",
"class":"cell txt l",
"children":[
"Glutamate NMDA antagonist"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3fdd77",
"class":"cell txt l",
"children":[
"Amantadine, rimantidine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3eca5b",
"class":"cell txt l",
"children":[
"Dyskinesia, tremor, fatigue"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"822438",
"class":"cell txt l",
"children":[
"Anticholinergic agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7f5363",
"class":"cell txt l",
"children":[
"Trihexyphenidyl, benztropine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353af4",
"class":"cell txt l",
"children":[
"Tremor, mild benefit against parkinsonism, higher adverse effect profile in old age and dementia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5c6893",
"class":"cell txt l",
"children":[
"Antipsychotic agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"296b40",
"class":"cell txt l",
"children":[
"Pimavanserin, quetiapine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"341da7",
"class":"cell txt l",
"children":[
"Medication-induced psychosis, medication-reduction strategies should be prioritized, increased mortality risk in patients with dementia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"140d33",
"class":"cell txt l",
"children":[
"Norepinephrine precursor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"997116",
"class":"cell txt l",
"children":[
"Droxidopa"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a59ea4",
"class":"cell txt l",
"children":[
"Neurogenic orthostatic hypotension, requires coadministration with carbidopa; other measures (including liberal salt intake, fludrocortisone, and midodrine) also are effective"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"NMDA = ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"N"
]
},
"-methyl-",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"D"
]
},
"-aspartate."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Available in Europe but not the United States."
]
]
},
"mk19_a_nr_t35":{
"id":"mk19_a_nr_t35",
"number":35,
"bookId":"nr",
"title":{
"__html":"Medications Causing Drug-Induced Parkinsonism"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b552c2",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 35. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t35"
}
]
},
"Medications Causing Drug-Induced Parkinsonism"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4d885",
"class":"col hd l",
"children":[
"Medication Class"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff7c0f",
"class":"col hd l",
"children":[
"Examples"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d13bc5",
"class":"cell txt l",
"children":[
"Common"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9df9b2",
"class":"cell txt li",
"children":[
"Dopamine receptor blockers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b6aeb",
"class":"cell txt l",
"children":[
"Typical antipsychotics: haloperidol, chlorpromazine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"783d41",
"class":"cell txt l",
"children":[
"Atypical antipsychotics: risperidone, olanzapine, ziprasidone, aripiprazole"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25d929",
"class":"cell txt l",
"children":[
"Antiemetics: metoclopramide, prochlorperazine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4fc56",
"class":"cell txt li",
"children":[
"Dopamine depleters"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9577fe",
"class":"cell txt l",
"children":[
"Tetrabenazine, reserpine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a4fd1f",
"class":"cell txt l",
"children":[
"Uncommon"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c88a0",
"class":"cell txt li",
"children":[
"Mood stabilizers, antiepileptic agents"
]
},
" ",
{
"type":"p",
"hlId":"6311ae",
"class":"cell txt li",
"children":[
"Other"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7050f5",
"class":"cell txt l",
"children":[
"Lithium, valproic acid"
]
},
" ",
{
"type":"p",
"hlId":"983036",
"class":"cell txt l",
"children":[
"Amiodarone, flunarizine (rarely), selective serotonin reuptake inhibitors"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t36":{
"id":"mk19_a_nr_t36",
"number":36,
"bookId":"nr",
"title":{
"__html":"Extrapyramidal Complications of Dopamine Receptor Blockers"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"64096e",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 36. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t36"
}
]
},
"Extrapyramidal Complications of Dopamine Receptor Blockers"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23ce6a",
"class":"col hd l",
"children":[
"Type of Movement Disorder"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd2968",
"class":"col hd l",
"children":[
"Symptoms"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7594b3",
"class":"cell txt l",
"children":[
"Acute reactions (reversible)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a37e9",
"class":"cell txt li",
"children":[
"Acute dystonia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"015810",
"class":"cell txt l",
"children":[
"Immediate dystonic spasms; often involves neck, face, larynx, and eyes (oculogyric crisis); rapid reversal with intravenous diphenhydramine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d29d8",
"class":"cell txt li",
"children":[
"Acute akathisia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"52ae26",
"class":"cell txt l",
"children":[
"Immediate sensation of restlessness with urge to constantly move and pace"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e6bd9",
"class":"cell txt l",
"children":[
"Subacute or chronic syndromes (reversible)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e39b35",
"class":"cell txt li",
"children":[
"Parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea004b",
"class":"cell txt l",
"children":[
"Similar to Parkinson disease, dose dependent, resolves within months after removal of the offending agent; symmetry and absence of nonmotor features favor a drug-induced over an idiopathic cause"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e29ad",
"class":"cell txt l",
"children":[
"Tardive syndromes (late onset, may be irreversible)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a614da",
"class":"cell txt li",
"children":[
"Tardive dyskinesia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d2f442",
"class":"cell txt l",
"children":[
"Repetitive stereotyped choreiform movements, oral-buccal-lingual predominance (tongue protrusion, lip smacking, puckering and chewing movements), also can affect the extremities (piano playing movements, foot tapping) and trunk (including respiratory muscles)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05a981",
"class":"cell txt li",
"children":[
"Tardive dystonia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"34961c",
"class":"cell txt l",
"children":[
"Sustained dystonic posturing commonly affecting the face, neck, trunk, and arms; extensor cervical and axial dystonia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72cd3c",
"class":"cell txt li",
"children":[
"Tardive akathisia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75dd4d",
"class":"cell txt l",
"children":[
"Chronic sensation of inner restlessness with urge to constantly move and pace, leg crossing, body rocking"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"55420c",
"class":"cell txt li",
"children":[
"Tardive tics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c25d91",
"class":"cell txt l",
"children":[
"Clinical presentation similar to Tourette syndrome but triggered after exposure to dopamine blockers"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"55b4ba",
"class":"cell txt l",
"children":[
"Other disorders"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0b351",
"class":"cell txt li",
"children":[
"Withdrawal emergent syndrome (reversible)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e729f",
"class":"cell txt l",
"children":[
"Choreiform dyskinesia starting after sudden withdrawal from a neuroleptic agent and stopping with reinstitution of the causative agent (or another agent from same class) and a subsequent slow taper within a few months; differential diagnosis of tardive dyskinesia that may be masked by antipsychotic agents and only unmasked after their removal (and may become persistent)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6a136e",
"class":"cell txt li",
"children":[
"Neuroleptic malignant syndrome (treatable emergency)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"afefa9",
"class":"cell txt l",
"children":[
"Idiosyncratic; rapid onset and progressive; rigidity, dystonia, hyperthermia, rhabdomyolysis, and altered mental status"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t37":{
"id":"mk19_a_nr_t37",
"number":37,
"bookId":"nr",
"title":{
"__html":"Classification of Tremors"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"409332",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 37. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t37"
}
]
},
"Classification of Tremors"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1aaa7e",
"class":"col hd l",
"children":[
"Tremor Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e8b7ed",
"class":"col hd l",
"children":[
"Disease Association"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"252034",
"class":"cell txt l",
"children":[
"Resting tremor",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"04779a",
"class":"cell txt li",
"children":[
"Parkinsonian resting tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fb6891",
"class":"cell txt l",
"children":[
"Parkinson disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e1398e",
"class":"cell txt l",
"children":[
"Asymmetric; may emerge during ambulation; associated with other parkinsonian signs (rigidity, bradykinesia, gait impairment)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e25075",
"class":"cell txt l",
"children":[
"Atypical, drug-induced, and vascular parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67261f",
"class":"cell txt l",
"children":[
"Similar to Parkinson disease; tremor sometimes symmetric; red flags for atypical parkinsonism sometimes present"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2752b5",
"class":"cell txt li",
"children":[
"Dystonic tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"769e68",
"class":"cell txt l",
"children":[
"Dystonia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"410c53",
"class":"cell txt l",
"children":[
"Associated with dystonic posturing; seen both at rest and with action; task specificity seen with action; position dependent, with a null point at which tremor stops"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"73575a",
"class":"cell txt l",
"children":[
"Action tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"001edb",
"class":"cell txt li",
"children":[
"Postural and kinetic tremor",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f83eb4",
"class":"cell txt l",
"children":[
"Essential tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"952c82",
"class":"cell txt l",
"children":[
"Present in the outstretched arm position and with various actions; commonly (but not universally) associated with a positive family history and improvement with alcohol; possible presence of head and voice tremor; possible emergence (after a delay of several seconds) of a postural tremor of the outstretched arms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e63408",
"class":"cell txt l",
"children":[
"Enhanced physiologic tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd7946",
"class":"cell txt l",
"children":[
"Noticeable form of physiologic low-amplitude, high-frequency tremor seen in association with triggers, such as stress, caffeine, drugs, and thyroid disease; similar to essential tremor but resolves with resolution of underlying trigger"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e9f6d6",
"class":"cell txt li",
"children":[
"Intention tremor",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"915201",
"class":"cell txt l",
"children":[
"Cerebellar disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b5b35",
"class":"cell txt l",
"children":[
"Tremor during movements that increases in amplitude as hand approaches target (also known as terminal tremor); possible association with other cerebellar symptoms, including dysmetria"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt li",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aac0f7",
"class":"cell txt l",
"children":[
"Severe essential tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b2ddb",
"class":"cell txt l",
"children":[
"Terminal tremor can be seen but often without prominent cerebellar dysmetria"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a18e3",
"class":"cell txt l",
"children":[
"Fragile X-associated tremor/ataxia syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b06d3",
"class":"cell txt l",
"children":[
"Neurodegenerative disease seen in older men who are carriers of a premutation in the fragile X intellectual disability 1 gene; typically, there is a family history of intellectual disability in young males and premature ovarian failure in females; symptoms of (intention) tremor, ataxia, parkinsonism, neuropathy and dementia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d86656",
"class":"cell txt li",
"children":[
"Rubral tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59c66d",
"class":"cell txt l",
"children":[
"Cerebellar outflow disorders (multiple sclerosis, stroke, traumatic brain injury)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"41ee4b",
"class":"cell txt l",
"children":[
"Coarse proximal tremor present at rest, worse with posturing (especially large-amplitude and proximal tremors in the wing-beating position with elbows flexed), and most severe during movements"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"74396e",
"class":"cell txt li",
"children":[
"Task-specific tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"486e3a",
"class":"cell txt l",
"children":[
"Primary writing tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f61452",
"class":"cell txt l",
"children":[
"Only present with specific task"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ed72c3",
"class":"cell txt li",
"children":[
"Orthostatic tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ed72c3",
"class":"cell txt l",
"children":[
"Orthostatic tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"769d99",
"class":"cell txt l",
"children":[
"High-frequency tremor emerging in the legs only during standing (orthostatic position) and resolving with sitting or walking"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4bc573",
"class":"cell txt li",
"children":[
"Neuropathic tremor"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1cb480",
"class":"cell txt l",
"children":[
"Demyelinating neuropathies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff8caa",
"class":"cell txt l",
"children":[
"Action tremor, associated with weakness, areflexia, and sensory loss"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Tremor present with the affected extremity resting unsupported."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Postural tremor is present with the arm in an outstretched position, and kinetic tremor is present during reaching, writing, and other movements."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Intention tremor is a specific subtype of kinetic tremor that becomes very prominent near target, exhibiting a crescendo of increased severity at the terminal section of the movement path."
]
]
},
"mk19_a_nr_t38":{
"id":"mk19_a_nr_t38",
"number":38,
"bookId":"nr",
"title":{
"__html":"Medications Causing Drug-Induced Action Tremor"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"ae71bc",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 38. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t38"
}
]
},
"Medications Causing Drug-Induced Action Tremor"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4d885",
"class":"col hd l",
"children":[
"Medication Class"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff7c0f",
"class":"col hd l",
"children":[
"Examples"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97abe3",
"class":"cell txt l",
"children":[
"β-Adrenergic agonists"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a16c0",
"class":"cell txt l",
"children":[
"Albuterol, terbutaline, theophylline"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3320b",
"class":"cell txt l",
"children":[
"Stimulants"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3dcc33",
"class":"cell txt l",
"children":[
"Amphetamines, methylphenidate, nicotine, caffeine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05cf6b",
"class":"cell txt l",
"children":[
"Mood stabilizers/antiepileptic drugs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f97822",
"class":"cell txt l",
"children":[
"Lithium, valproic acid, carbamazepine, lamotrigine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ad4d62",
"class":"cell txt l",
"children":[
"Neuroleptic agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"edfaab",
"class":"cell txt l",
"children":[
"Haloperidol, olanzapine (postural and at rest)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ae55a",
"class":"cell txt l",
"children":[
"Tricyclic antidepressants"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c5a602",
"class":"cell txt l",
"children":[
"Amitriptyline"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0c7b03",
"class":"cell txt l",
"children":[
"Selective serotonin reuptake inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0f638",
"class":"cell txt l",
"children":[
"Fluoxetine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"daa5d9",
"class":"cell txt l",
"children":[
"Immunosuppressant agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"069790",
"class":"cell txt l",
"children":[
"Cyclosporine, tacrolimus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2c055d",
"class":"cell txt l",
"children":[
"Other agents"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b40b8c",
"class":"cell txt l",
"children":[
"Amiodarone, procainamide, mexiletine, levothyroxine, verapamil, atorvastatin, glucocorticoids, antihistamines"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t39":{
"id":"mk19_a_nr_t39",
"number":39,
"bookId":"nr",
"title":{
"__html":"Classification of Dystonia"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9009ed",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 39. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t39"
}
]
},
"Classification of Dystonia"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a1f72",
"class":"col hd l",
"children":[
"Clinical Feature"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"071b87",
"class":"col hd l",
"children":[
"Subtype"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28add6",
"class":"cell txt l",
"children":[
"Age of onset"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"afe0d5",
"class":"cell txt l",
"children":[
"Infancy, childhood (<13 years), adolescence (13-18 years), young adulthood (18-40 years), late adulthood (>40 years)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9967dc",
"class":"cell txt l",
"children":[
"Temporal pattern"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c54eee",
"class":"cell txt l",
"children":[
"Persistent, paroxysmal, action induced"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5477bb",
"class":"cell txt l",
"children":[
"Associated neurologic features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"322a90",
"class":"cell txt l",
"children":[
"Isolated dystonia (no other deficits), dystonia plus (with parkinsonism or myoclonus)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64db63",
"class":"cell txt l",
"children":[
"Anatomic distribution"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ca01c",
"class":"cell txt l",
"children":[
"Focal, segmental (contiguous regions), multifocal (noncontiguous regions), hemidystonia (affecting half of the body), generalized (trunk plus two other regions)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"149bd2",
"class":"cell txt l",
"children":[
"Paroxysmal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b7ebea",
"class":"cell txt l",
"children":[
"Primary genetic paroxysmal dyskinesia (kinesigenic, nonkinesigenic, exercise induced, hypnogenic), secondary paroxysmal dyskinesia (stroke, demyelination)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d0008",
"class":"cell txt l",
"children":[
"Diurnal variation (better in morning)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e09c92",
"class":"cell txt l",
"children":[
"Dopa-responsive dystonia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50fc9b",
"class":"col hd l",
"children":[
"Cause"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a5273",
"class":"col hd l",
"children":[
"Example"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59771d",
"class":"cell txt l",
"children":[
"Genetic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d8f76",
"class":"cell txt l",
"children":[
"Autosomal dominant (DYT1, DYT6, ATP1A3), autosomal recessive (Wilson disease), X-linked (Lesch-Nyhan syndrome), mitochondrial (Leigh syndrome)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"31e897",
"class":"cell txt l",
"children":[
"Structural lesion"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6682bd",
"class":"cell txt l",
"children":[
"Hemidystonia secondary to stroke, vascular malformation, or lesion in contralateral basal ganglia; postencephalitis, posttraumatic, postanoxic"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"923999",
"class":"cell txt l",
"children":[
"Neurodegeneration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f6e2d",
"class":"cell txt l",
"children":[
"Parkinson disease, Parkinson-plus syndromes, Huntington disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"71ec80",
"class":"cell txt l",
"children":[
"Perinatal brain injury"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"92aed1",
"class":"cell txt l",
"children":[
"Dystonia associated with cerebral palsy, delayed-onset dystonia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3cfc12",
"class":"cell txt l",
"children":[
"Sporadic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2bd79",
"class":"cell txt l",
"children":[
"Adult-onset focal dystonia (torticollis, blepharospasm, writer's cramp, musician's cramp, spasmodic dysphonia), Meige syndrome (facial and oromandibular segmental dystonia)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e48bab",
"class":"cell txt l",
"children":[
"Psychological"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"128eac",
"class":"cell txt l",
"children":[
"Psychogenic dystonia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba25cf",
"class":"cell txt l",
"children":[
"Medications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f318c5",
"class":"cell txt l",
"children":[
"Neuroleptic-induced tardive dystonia, antiemetic-induced acute dystonic reaction"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t40":{
"id":"mk19_a_nr_t40",
"number":40,
"bookId":"nr",
"title":{
"__html":"Causes of Chorea"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"6cf4c3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 40. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t40"
}
]
},
"Causes of Chorea"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50fc9b",
"class":"col hd l",
"children":[
"Cause"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a5273",
"class":"col hd l",
"children":[
"Example"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba25cf",
"class":"cell txt l",
"children":[
"Medications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72684f",
"class":"cell txt l",
"children":[
"Antipsychotic agents, estrogen-containing drugs, levodopa, amphetamines, methylphenidate, lithium, phenytoin, opioids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b1e9b",
"class":"cell txt l",
"children":[
"Pregnancy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b83c6",
"class":"cell txt l",
"children":[
"Chorea gravidarum"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"327a97",
"class":"cell txt l",
"children":[
"Endocrine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8236d7",
"class":"cell txt l",
"children":[
"Hyperglycemia (especially acute), thyrotoxicosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f0ddc0",
"class":"cell txt l",
"children":[
"Infection"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"660213",
"class":"cell txt l",
"children":[
"Streptococcal (Sydenham chorea), prion disease, herpes encephalitis, HIV"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b9a54",
"class":"cell txt l",
"children":[
"Autoimmune"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b4cfb5",
"class":"cell txt l",
"children":[
"Systemic lupus erythematosus, antiphospholipid syndrome, anti-GAD antibody, celiac disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f6bbc",
"class":"cell txt l",
"children":[
"Paraneoplastic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"047fb7",
"class":"cell txt l",
"children":[
"Anti-CRMP5 antibody, anti-NMDA antibody (orofacial and limb dyskinesias), LGI1 antibody, CASPR2 antibody, IgLON5 antibody"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59771d",
"class":"cell txt l",
"children":[
"Genetic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3a562",
"class":"cell txt l",
"children":[
"Benign hereditary chorea, neuroferritinopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d34d6d",
"class":"cell txt l",
"children":[
"Neurodegenerative"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f03819",
"class":"cell txt l",
"children":[
"Huntington disease, Huntington-like disease 2, spinocerebellar ataxia 17 and 8, C9orf72 expansion syndrome, Friedreich ataxia, chorea-acanthocytosis, neurodegeneration with brain iron accumulation"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"CASPR2 = contactin-associated protein 2; CRMP5 = collapsin response mediator protein 5; GAD = glutamic acid decarboxylase; IgLON5 = IgLON family member 5; LGI1 = leucine-rich, glioma inactivated 1; NMDA = ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"N"
]
},
"-methyl-",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"D"
]
},
"-aspartate."
]
]
},
"mk19_a_nr_t41":{
"id":"mk19_a_nr_t41",
"number":41,
"bookId":"nr",
"title":{
"__html":"Causes of Acquired Myoclonus"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"c86f57",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 41. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t41"
}
]
},
"Causes of Acquired Myoclonus"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50fc9b",
"class":"col hd l",
"children":[
"Cause"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a5273",
"class":"col hd l",
"children":[
"Example"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98f770",
"class":"col hd l",
"children":[
"Features"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a44d2",
"class":"cell txt l",
"children":[
"Metabolic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f4549",
"class":"cell txt l",
"children":[
"Kidney, hepatic, or respiratory failure; sleep apnea; hyponatremia; hypocalcemia; hyperglycemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd05ff",
"class":"cell txt l",
"children":[
"Both positive and negative myoclonus (asterixis)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"327a97",
"class":"cell txt l",
"children":[
"Endocrine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c98801",
"class":"cell txt l",
"children":[
"Hyperthyroidism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"267696",
"class":"cell txt l",
"children":[
"With tremor and ophthalmopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e8bc6",
"class":"cell txt l",
"children":[
"Toxic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9d74f",
"class":"cell txt l",
"children":[
"Opioids, gabapentin, amiodarone, SSRIs, quinolone antibiotics, lamotrigine, phenytoin, lithium"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d72c52",
"class":"cell txt l",
"children":[
"Prominent in serotonin syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"313760",
"class":"cell txt l",
"children":[
"Infectious"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a4f456",
"class":"cell txt l",
"children":[
"Lyme disease, Whipple disease, viral encephalitis (especially herpes), prion disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"81da55",
"class":"cell txt l",
"children":[
"Oculomasticatory myorhythmia (rhythmic movements of eye convergence with chewing) in Whipple"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f6bbc",
"class":"cell txt l",
"children":[
"Paraneoplastic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e2c5f",
"class":"cell txt l",
"children":[
"Opsoclonus-myoclonus syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cdf3f3",
"class":"cell txt l",
"children":[
"Anti-Ri antibody"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b9a54",
"class":"cell txt l",
"children":[
"Autoimmune"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a2bfa",
"class":"cell txt l",
"children":[
"Celiac disease, associated with thyroid antibodies, DPPX antibody encephalitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eacf19",
"class":"cell txt l",
"children":[
"With other symptoms, such as ataxia or encephalopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89fced",
"class":"cell txt l",
"children":[
"Cortical pathology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97c2b9",
"class":"cell txt l",
"children":[
"Epileptic myoclonus (primary and secondary myoclonic epilepsies), posthypoxic myoclonus (Lance-Adams syndrome), corticobasal degeneration, advanced Alzheimer disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a838b0",
"class":"cell txt l",
"children":[
"Epileptic activity on EEG, giant somatosensory evoked potentials"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e95cdd",
"class":"cell txt l",
"children":[
"Basal ganglia pathology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f04d50",
"class":"cell txt l",
"children":[
"Myoclonus dystonia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea5547",
"class":"cell txt l",
"children":[
"Genetic, associated with dystonia, alcohol-sensitive"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fe8ee2",
"class":"cell txt l",
"children":[
"Brainstem pathology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"847682",
"class":"cell txt l",
"children":[
"Brainstem reticular myoclonus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"07bed2",
"class":"cell txt l",
"children":[
"Stimulus-sensitive (noise or action) myoclonus, coordinated flexion of trunk and limbs"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89b62b",
"class":"cell txt l",
"children":[
"Cord pathology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5024ae",
"class":"cell txt l",
"children":[
"Segmental spinal myoclonus, propriospinal myoclonus, multiple sclerosis, cord tumor or trauma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cec5af",
"class":"cell txt l",
"children":[
"Jerks in limited myotomes (segmental) or spreading distally and proximally (propriospinal), associated with myelopathy signs"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6f5fc",
"class":"cell txt l",
"children":[
"Peripheral nerve pathology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d576d",
"class":"cell txt l",
"children":[
"Hemifacial spasm"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d06bd9",
"class":"cell txt l",
"children":[
"Focal compression or irritation of the facial nerve (cranial nerve VII)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"DPPX = dipeptidyl peptidase–like protein 6; EEG = electroencephalography; SSRI = selective serotonin reuptake inhibitor."
]
]
}
}
}